EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Circulating Growth Differentiation Factor-15 Levels are Associated with Early Echocardiographic Signs of Diastolic Function Impairment in the STANISLAS Cohort: A 20-Year Follow-Up Study

Luca Monzo iD, Constance Xhaard, João Pedro Ferreira, Guillaume Baudry, Zohra Lamiral, Kevin Duarte, Erwan Bozec, Jean-Marc Boivin, Olivier Huttin, Patrick Rossignol, Faiez Zannad, Nicolas Girerd

European Journal of Heart Failure · 01.07.2025 · 27 (7) · 1202-1211

DOI: 10.1002/ejhf.3576 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Heart Failure, online erschienen am 21.01.2025. Verfasst von Luca Monzo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Université de Lorraine, INSERM, Centre d'Investigations Cliniques Plurithématique 1433, Inserm U1116, CHRU de Nancy and F-CRIN INI-CRCT, Nancy, Franc…. Hauptthemen laut MEDLINE: Growth Differentiation Factor 15, Ventricular Dysfunction, Left, Stroke Volume, Heart Ventricles. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Center Hospitalier Régional Universitaire of Nancy (CHRU), French Ministry of Health (Program Hospitalier de Recherche Clinique Inter-régional 2013), Contrat de Plan Etat-Lorraine and Fonds Européen de Développement Régional (FEDER Lorraine).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Early identification of healthy subjects prone to develop cardiac dysfunction may be instrumental to prevention strategies. Our study aimed to evaluate whether circulating levels of growth differentiation factor-15 (GDF-15) could predict adverse changes in echocardiographic indexes of cardiac structure and function in an initially healthy populational familial cohort with a long follow-up (STANISLAS cohort). Methods and results We evaluated 1679 participants (49 ± 14 years, 48% males) included in the fourth visit (V4) of the STANISLAS cohort with available GDF-15 measurements (Olink proteomic analysis) and echocardiographic parameters. Among them, 1562 had also GDF-15 measurements at the first visit (V1) (18.2 ± 1.4 years before V4). We evaluated both prospective (GDF-15 at V1) and cross-sectional (GDF-15 at V4) associations between GDF-15 levels and echocardiographic variables. In adjusted analyses, higher baseline GDF-15 levels were associated with lower left ventricular (LV) end-diastolic volume and higher E/e' ratio nearly two decades later (both p ≤ 0.01). The cross-sectional analysis at V4 also found significant associations between GDF-15 and LV end-diastolic volume and higher E/e' ratio, further identifying significant associations with impaired LV strain.

Conclusion

In the STANISLAS cohort, initial circulating GDF-15 levels were associated with echocardiographic signs of reduced LV size and increased filling pressure almost two decades later. This association was also confirmed by evaluating GDF-15 at the follow-up visit (V4). These findings suggest a potential role for GDF-15 as an easy screening and prognostic tool of diastolic dysfunction in the general population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Growth Differentiation Factor 15Ventricular Dysfunction, LeftStroke VolumeHeart VentriclesVentricular Function, LeftHumansMaleFemaleFollow-Up StudiesMiddle AgedEchocardiographyCross-Sectional StudiesBiomarkersProspective StudiesDiastoleAdultTime Factors

Stichwörter der Autor:innen

Cohort studyDiastolic dysfunctionEchocardiographyGrowth differentiation factor‐15

Substanzen

Growth Differentiation Factor 15GDF15 protein, humanBiomarkers

Autor:innen und Institutionen

  • Université de Lorraine, INSERM, Centre d'Investigations Cliniques Plurithématique 1433, Inserm U1116, CHRU de Nancy and F-CRIN INI-CRCT, Nancy, France.
  • Cardiovascular Research and Development Center, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portugal.
  • Department of Medicine and Nephrology-Haemodialysis, Princess Grace Hospital, Monaco, Monaco.
  • Monaco Private Haemodialysis Centre, Monaco, Monaco.

ORCID-Profile: Luca Monzo

Förderung

  • Center Hospitalier Régional Universitaire of Nancy (CHRU)
  • French Ministry of Health (Program Hospitalier de Recherche Clinique Inter-régional 2013)
  • Contrat de Plan Etat-Lorraine and Fonds Européen de Développement Régional (FEDER Lorraine)

Zitieren

APA

Monzo, L., Xhaard, C., Ferreira, J. P., Baudry, G., Lamiral, Z., Duarte, K., Bozec, E., Boivin, J. M., Huttin, O., Rossignol, P., Zannad, F., & Girerd, N. (2025). Circulating Growth Differentiation Factor-15 Levels are Associated with Early Echocardiographic Signs of Diastolic Function Impairment in the STANISLAS Cohort: A 20-Year Follow-Up Study. European Journal of Heart Failure, 27(7), 1202-1211. https://doi.org/10.1002/ejhf.3576

Vancouver

Monzo L, Xhaard C, Ferreira JP, Baudry G, Lamiral Z, Duarte K, et al. Circulating Growth Differentiation Factor-15 Levels are Associated with Early Echocardiographic Signs of Diastolic Function Impairment in the STANISLAS Cohort: A 20-Year Follow-Up Study. European Journal of Heart Failure. 2025;27(7):1202-1211. doi:10.1002/ejhf.3576

BibTeX
@article{Monzo2025,
  author = {Monzo, Luca and Xhaard, Constance and Ferreira, João Pedro and Baudry, Guillaume and Lamiral, Zohra and Duarte, Kevin and Bozec, Erwan and Boivin, Jean-Marc and Huttin, Olivier and Rossignol, Patrick and Zannad, Faiez and Girerd, Nicolas},
  title = {Circulating Growth Differentiation Factor-15 Levels are Associated with Early Echocardiographic Signs of Diastolic Function Impairment in the STANISLAS Cohort: A 20-Year Follow-Up Study},
  journal = {European Journal of Heart Failure},
  year = {2025},
  volume = {27},
  number = {7},
  pages = {1202--1211},
  doi = {10.1002/ejhf.3576}
}
Kostenlos starten →